Brandon Folkes
Stock Analyst at H.C. Wainwright
(0.86)
# 3,806
Out of 4,456 analysts
482
Total ratings
41%
Success rate
-1%
Average return
Main Sectors:
Stocks Rated by Brandon Folkes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMER Omeros | Reiterated: Buy | $40 → $33 | $8.67 | +280.62% | 23 | Jun 26, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $7 | $2.19 | +219.63% | 15 | Jun 25, 2026 | |
| ACHV Achieve Life Sciences | Reiterated: Buy | $12 | $6.02 | +99.34% | 13 | Jun 23, 2026 | |
| ENTA Enanta Pharmaceuticals | Reiterated: Buy | $20 | $14.00 | +42.86% | 11 | Jun 23, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $26 | $13.52 | +92.31% | 12 | Jun 23, 2026 | |
| TRAW Traws Pharma | Downgraded: Hold | $8 → $1 | $0.827 | +20.92% | 4 | Jun 18, 2026 | |
| HRTX Heron Therapeutics | Maintained: Buy | $2 | $0.43 | +365.12% | 38 | Jun 8, 2026 | |
| TLPH Talphera | Initiated Coverage: Buy | $4 → $3 | $1.03 | +192.68% | 19 | Jun 5, 2026 | |
| MNKD MannKind | Reiterated: Buy | $10 | $4.14 | +141.55% | 22 | Jun 1, 2026 | |
| RNTX Rein Therapeutics | Reiterated: Buy | $10 → $8 | $0.9712 | +723.72% | 7 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.7359 | +1,394.77% | 8 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.24 | +545.16% | 14 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12.77 | $1.51 | +745.73% | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $5.19 | +246.82% | 8 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $7.06 | +310.76% | 8 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.92 | +420.83% | 2 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $7.85 | +65.61% | 12 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $29.03 | +106.68% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.75 | +173.68% | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15.61 | $9.38 | +66.40% | 15 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $6.62 | +96.37% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 | $84.50 | +43.20% | 21 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $36.59 | +63.98% | 40 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $7.69 | +30.04% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $18.15 | +15.70% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $41.83 | +14.75% | 6 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $200 | $2.56 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.651 | n/a | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $16 | $8.53 | n/a | 29 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $4 | $2.92 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $10 | $0.9788 | n/a | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 2 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 → $33 | $0.67 | n/a | 18 | Mar 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $15 | $3.01 | n/a | 15 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $260.93 | n/a | 1 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $40 | $0.891 | n/a | 2 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.001 | n/a | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $50 | $0.0015 | n/a | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $32 | $55.08 | n/a | 12 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $25 | $44.93 | n/a | 3 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $230.02 | n/a | 10 | Oct 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $8 | $0.000001 | n/a | 4 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $23.88 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $12 | $9.60 | n/a | 9 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $33 | $17.33 | n/a | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $30 | $31.69 | n/a | 2 | Sep 12, 2016 |
Omeros
Jun 26, 2026
Reiterated: Buy
Price Target: $40 → $33
Current: $8.67
Upside: +280.62%
Connect Biopharma Holdings
Jun 25, 2026
Reiterated: Buy
Price Target: $7
Current: $2.19
Upside: +219.63%
Achieve Life Sciences
Jun 23, 2026
Reiterated: Buy
Price Target: $12
Current: $6.02
Upside: +99.34%
Enanta Pharmaceuticals
Jun 23, 2026
Reiterated: Buy
Price Target: $20
Current: $14.00
Upside: +42.86%
Zevra Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $26
Current: $13.52
Upside: +92.31%
Traws Pharma
Jun 18, 2026
Downgraded: Hold
Price Target: $8 → $1
Current: $0.827
Upside: +20.92%
Heron Therapeutics
Jun 8, 2026
Maintained: Buy
Price Target: $2
Current: $0.43
Upside: +365.12%
Talphera
Jun 5, 2026
Initiated Coverage: Buy
Price Target: $4 → $3
Current: $1.03
Upside: +192.68%
MannKind
Jun 1, 2026
Reiterated: Buy
Price Target: $10
Current: $4.14
Upside: +141.55%
Rein Therapeutics
Jun 1, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $0.9712
Upside: +723.72%
Jun 1, 2026
Reiterated: Buy
Price Target: $11
Current: $0.7359
Upside: +1,394.77%
May 26, 2026
Maintained: Buy
Price Target: $8
Current: $1.24
Upside: +545.16%
May 26, 2026
Maintained: Buy
Price Target: $12.77
Current: $1.51
Upside: +745.73%
May 26, 2026
Reiterated: Buy
Price Target: $18
Current: $5.19
Upside: +246.82%
May 26, 2026
Maintained: Buy
Price Target: $29
Current: $7.06
Upside: +310.76%
May 20, 2026
Reiterated: Buy
Price Target: $10
Current: $1.92
Upside: +420.83%
May 15, 2026
Reiterated: Buy
Price Target: $13
Current: $7.85
Upside: +65.61%
May 15, 2026
Reiterated: Buy
Price Target: $60
Current: $29.03
Upside: +106.68%
May 14, 2026
Reiterated: Buy
Price Target: $13
Current: $4.75
Upside: +173.68%
May 14, 2026
Reiterated: Buy
Price Target: $15.61
Current: $9.38
Upside: +66.40%
May 14, 2026
Reiterated: Buy
Price Target: $13
Current: $6.62
Upside: +96.37%
May 8, 2026
Reiterated: Buy
Price Target: $121
Current: $84.50
Upside: +43.20%
May 8, 2026
Reiterated: Buy
Price Target: $60
Current: $36.59
Upside: +63.98%
May 8, 2026
Reiterated: Buy
Price Target: $10
Current: $7.69
Upside: +30.04%
May 8, 2026
Reiterated: Buy
Price Target: $21
Current: $18.15
Upside: +15.70%
May 1, 2026
Reiterated: Buy
Price Target: $48
Current: $41.83
Upside: +14.75%
Mar 4, 2025
Reiterated: Buy
Price Target: $8 → $200
Current: $2.56
Upside: n/a
Nov 14, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $0.651
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $23 → $16
Current: $8.53
Upside: n/a
May 3, 2024
Maintained: Buy
Price Target: $3 → $4
Current: $2.92
Upside: n/a
May 12, 2023
Maintained: Buy
Price Target: $20 → $10
Current: $0.9788
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Mar 13, 2023
Maintained: Hold
Price Target: $37 → $33
Current: $0.67
Upside: n/a
Feb 9, 2023
Maintained: Buy
Price Target: $22 → $15
Current: $3.01
Upside: n/a
Feb 3, 2023
Reiterated: Buy
Price Target: $48
Current: $260.93
Upside: n/a
Nov 22, 2022
Maintained: Buy
Price Target: $22 → $40
Current: $0.891
Upside: n/a
Nov 2, 2022
Initiated Coverage: Buy
Price Target: $5
Current: $0.001
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $5 → $50
Current: $0.0015
Upside: n/a
Jan 27, 2022
Upgraded: Buy
Price Target: $22 → $32
Current: $55.08
Upside: n/a
Nov 4, 2021
Reiterated: Buy
Price Target: $23 → $25
Current: $44.93
Upside: n/a
Oct 6, 2021
Maintained: Buy
Price Target: $210
Current: $230.02
Upside: n/a
Aug 9, 2021
Maintained: Buy
Price Target: $6 → $8
Current: $0.000001
Upside: n/a
Jun 30, 2021
Initiated Coverage: Buy
Price Target: $45
Current: $23.88
Upside: n/a
May 6, 2021
Maintained: Buy
Price Target: $18 → $12
Current: $9.60
Upside: n/a
Dec 15, 2020
Reiterated: Buy
Price Target: $25 → $33
Current: $17.33
Upside: n/a
Sep 12, 2016
Reiterated: Buy
Price Target: $34 → $30
Current: $31.69
Upside: n/a